Ling Ding
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
BCMA-CD19 armored compound CAR T cells in systemic lupus erythematosus: extended follow-up of a phase 1 clinical trial.
Journal: Journal of hematology & oncology
Published: December 08, 2025
Biomaterial and Hydrogel Strategies for Regenerative Microenvironment Reconstruction in Peripheral Nerve Conduits.
Journal: Gels (Basel, Switzerland)
Published: October 04, 2025
Successful Spontaneous Pregnancies and Healthy Neonates After Dual-Target CAR-T Cell Therapy in Systemic Lupus Erythematosus.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 26, 2025
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up.
Journal: Stem cell reviews and reports
Published: June 11, 2025
Burden of knee osteoarthritis in China and globally: 1990-2045.
Journal: BMC musculoskeletal disorders
Published: March 12, 2025
Safe pregnancy and delivery in a female patient with systemic lupus erythematosus after discontinuation of dual-target chimeric antigen receptor T cells therapy
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: December 18, 2024
Lipoma arborescens in a 22-year-old male: A case report.
Journal: Medicine
Published: December 10, 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial.
Journal: Annals of the rheumatic diseases
Published: March 18, 2024
miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα.
Journal: Breast cancer (Tokyo, Japan)
Published: September 05, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026